Browse the evidence

No significant differences were observed in relative intensity between the 4-6 RPE and 7-9 RPE groups.

Resistance training programs can be designed with similar intensities without significant differences in outcomes.

There is no significant correlation between perceived muscle activation and EMG measured activation level for any exercise.

Practitioners should be cautious in using perceived muscle activation as an indicator of training intensity.

Self-reported muscle activation may not accurately correspond to actual muscle activation as measured via EMG.

Relying solely on perceived muscle activation for training decisions may lead to ineffective programming.

A neural network achieved an overall accuracy of 72.5% in predicting 12-month weight loss from baseline characteristics.

Utilizing neural network models may enhance the prediction of weight loss outcomes in clinical settings.

Patients with less-collapsible upper airways and low loop gain at baseline may be more likely to see improvements in their OSA severity after surgery.

Identifying patients with specific baseline characteristics may help tailor treatment approaches for OSA.

Tirzepatide is associated with a lower risk of dementia versus semaglutide (HR 0.69, 95% CI 0.48-0.99, p = 0.04).

Practitioners may consider tirzepatide as a potentially safer option for reducing dementia risk in patients with type 2 diabetes.

Patients with obesity face multiple barriers to cardiac rehabilitation participation and adherence.

Addressing these barriers is crucial for improving CR participation rates among obese patients.

Resistance training intensity was less than 40% of 1 repetition maximum in both young and older adults.

Practitioners should be aware that low-load resistance training may not effectively increase muscle strength and mass.

Cognitive scores were lower with increasing BF percentage and VAT.

Monitoring body fat percentage and visceral fat may be important for cognitive health.

Patients with persistent complete concentric velopharyngeal collapse in the supine position had a mean apnea–hypopnea index (AHI) of 54.7 events/h, significantly higher than the 60 patients without such collapse in position 4, who had a mean AHI of 35.5 events/h.

Clinicians should consider the severity of velopharyngeal collapse when assessing sleep apnea treatment options.

The study demonstrated the feasibility, safety, and usefulness of using a simple edge‐to‐edge, reusable oral appliance in drug-induced sleep endoscopy.

Oral appliances may be a viable option for patients undergoing sleep apnea evaluation.

Bioactive compounds affect appetite regulation through the central nervous system, peripheral hormones, and intestinal microbiota.

Practitioners should consider multiple pathways when addressing appetite regulation.

The proposed wireless acquisition system for grip force monitoring demonstrates excellent performance in real-time signal acquisition and grip force prediction.

Practitioners can utilize this system for effective muscle monitoring in various applications.

The grip force prediction model established using dual-channel sEMG signals achieved an R2 of 0.9215.

This high R2 value indicates reliable grip force predictions, useful for training and rehabilitation.

The system is characterized as portable, wearable, low-cost, and easy to operate.

The system's design makes it accessible for various users in fitness and rehabilitation settings.

Probability of mild cognitive impairment (MCI) or probable dementia (PD) differed by type 2 diabetes (T2D) subgroup.

Healthcare providers should consider T2D subgroup characteristics when assessing cognitive health risks.

The highest probability of MCI/PD was found in the T2D subgroup characterized by severe obesity.

Focus on weight management strategies in T2D patients to mitigate cognitive decline risks.

The incidence of peripheral neuropathy (PN) differs by type 2 diabetes (T2D) subgroup.

Healthcare providers should consider T2D subgroups when assessing PN risk.

GLP1-RA treatment is not associated with a significant difference in risk of serious psychiatric adverse events compared with placebo (log[RR] = -0.02; P = .87).

GLP1-RAs can be considered safe regarding serious psychiatric events in this population.

Hypothalamic inflammation and gliosis are present in children and adults with obesity.

Practitioners should consider hypothalamic inflammation as a factor in obesity management.

Patients prescribed semaglutide or tirzepatide had an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) with a hazard ratio of 1.76.

Clinicians should monitor patients on semaglutide or tirzepatide for signs of NAION.

Patients prescribed semaglutide or tirzepatide had an increased risk of other optic nerve disorders with a hazard ratio of 1.65.

Clinicians should be aware of the risk of other optic nerve disorders in patients on semaglutide or tirzepatide.

Continuous positive airway pressure therapy is the most widely prescribed treatment for obstructive sleep apnea.

Clinicians should consider CPAP as a first-line treatment for patients with obstructive sleep apnea.

Understanding the pathophysiological traits of OSA in each patient is crucial for effective treatment.

Practitioners should assess individual pathophysiological traits to tailor OSA treatments.